Feroscan

Feroscan specializes in the development of first-in-class personalized cytotoxics with a unique and innovative mode of action. The pipeline of the company focuses on intractable cancers; such as ovarian and triple negative breast cancers.

Year of creation: 2014

Line of business: Pharmaceuticals

Institut Curie: Behind the technology and R&D partner

TECHNOLOGY

Feroscan specializes in the development of first-in-class personalized cytotoxics with a unique and innovative mode of action. The pipeline of the company focuses on intractable cancers; such as ovarian and triple negative breast cancers.

APPLICATIONS

The company's pipeline targets orphan cancers in particular Ovarian lowox cancer, Triple negative breast cancer.